1 |
Hooi JKY, Lai WY, Ng WK, et al.Global Prevalence of Helicobacter pylori Infection:Systematic Review and Meta-Analysis[J].Gastroenterology, 2017, 153:420-429.
|
2 |
Lee YC, Chiang TH, Chou CK, et al.Association between Helicobacter pylori eradication and gastric cancer incidence:A systematic review and meta-analysis.Gastroenterology, 2016, 150:1113-1124.e5.
|
3 |
Uemura N, Okamoto S, Yamamoto S, et al.Helicobacter pylori infection and the development of gastric cancer[J].N Engl J Med, 2001, 345(11):784-789.
|
4 |
McColl KE.Clinical practice.Helicobacter pylori infection[J].N Engl J Med, 2010, 362(17):1597-1604.
|
5 |
Graham DY.Helicobacter pylori update:gastric cancer, reliable therapy, and possible benefits[J].Gastroenterology, 2015, 148:719-731.e3.
|
6 |
Sugano K, Tack J, Kuipers EJ, et al.Kyoto global consensus report on Helicobacter pylori gastritis[J].Gut, 2015, 64(9):1353-1367.
|
7 |
Huang HK, Wang JH, Lei WY, et al.Helicobacter pyloriinfection is associated with an increased risk of Parkinson′s disease:A population-based retrospective cohort study[J].Parkin-sonism Relat Disord, 2018, 47:26-31.
|
8 |
Jiang J, Chen Y, Shi J, et al.Population attributable burdenof Helicobacter pylori-related gastric cancer, coronary heart dis-ease, and ischemic stroke in China[J].Eur J Clin Microbiol In-fect Dis, 2017, 36(2):199-212.
|
9 |
Sugrañes-montalván A, Barreto-suárez E, Nico-lau-pestana E, et al.Relation between Helicobacter pyloriinfection and chronic urticarial[J].Rev Alerg Mex, 2017, 64(4):396-402.
|
10 |
Han X, Li Y, Wang J, et al.Helicobacter pylori infection is associated with type 2 diabetes among a middle-and old-age Chinese population[J].Diabetes Metab Res Rev, 2016, 32(1):95-101.
|
11 |
Nam SY, Ryu KH, Park BJ, et al.Effects of Helicobacterpylori infection and its eradication on lipid profiles and cardiovas-cular diseases[J].Helicobacter, 2015, 20(2):125-132.
|
12 |
Upala S, Jaruvongvanich V, Riangwiwat T, et al.Association between helicobacter pylori infection and metabolic syndrome:a systematic review and meta-analysis[J].J Dig Dis, 2016, 17(7):433-440.
|
13 |
Yang W, Xuan C.Influence of helicobacter pylori infection on metabolic syndrome in old Chinese People[J].Gastroenterol, 2016, 2016:6951264.
|
14 |
王巧明.幽门螺杆菌感染的诊断与治疗[J].中国临床保健杂志,2004,7(2):147-150.
|
15 |
陈志恒,徐灿霞,罗玲,等.长沙市体检人群幽门螺杆菌感染与胃黏膜改变及血脂的关系[J].中南大学学报(医学版),2014,39(3):265-269.
|
16 |
雷鸣,夏先考,汤兰桂,等.幽门螺杆菌感染对颈动脉粥样硬化患者超声形态及血脂代谢的影响[J].现代预防医学,2014,41(21):3990-3992.
|
17 |
宋增新.Hp感染对冠心病患者冠状动脉粥样硬化进展的作用分析[J].湖南师范大学学报(医学版),2017,14(5):152-154.
|
18 |
杨丽,雷鸣,郑睿东,等.幽门螺杆菌对冠心病病人血清同型半胱氨酸水平影响的研究[J].护理研究,2015(20):2524-2525.
|
19 |
于汶,宗力群,胡荣,等.幽门螺杆菌感染与颈动脉斑块及心血管病危险因素的关系[J].中国医药,2016,11(10):1442-1446.
|
20 |
郝志华,王俊明,陈春彦,等.幽门螺杆菌感染与颈动脉粥样硬化关系研究[J].中国医刊,2012,47(5):51-52.
|
21 |
Gen R, Demir M, Ataseven H, Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and lowgrade inflammation[J].South Med J, 2010, 103(10):190-196.
|
22 |
张颖,江勇.幽门螺杆菌与代谢疾病相关性的研究进展[J].中华全科医师杂志,2016,15(4):310-313.
|
23 |
陈晶,付娟,刘娜,等.幽门螺杆菌感染对冠心病患者相关指标及颈动脉硬化的影响[J].中华医院感染学杂志,2016,26(13):2972-2974.
|
24 |
鲁勇.幽门螺杆菌感染对冠心病患者血清生化水平及颈动脉硬化的影响[J].中国微生态学杂志,2017,29(9):1056-1062.
|
25 |
张鸿雁.老年急性冠脉综合征患者冠脉狭窄和脂质代谢紊乱程度与幽门螺杆菌感染的相关性[J].中国老年学杂志,2016,36(16):3951-3952.
|
26 |
陈旭,王志军,张志宇.幽门螺杆菌感染对冠心病患者血清生化指标影响的临床研究[J].中华医院感染学杂志,2014,(16):3942-3944.
|
27 |
Jaug SH, LCEH, Kim JS, et al.Association between Helicobacter pylori Infection and Cerebral Small Vessel Disease[J].Korean J Fam Med, 2015, 36(5):227-232.
|
28 |
陈晶,付娟,刘娜,等.幽门螺杆菌感染对冠心病患者相关指标及颈动脉硬化的影响[J].中华医院感染学杂志,2016,26(13):2972-2974.
|